Enoxacin, an agent that causes global upregulation of miRNA expression via binding trans-activation response RNA-binding protein (TRBP) and stabilizing dicer activity [47], appears to revert cancer phenotypes both in cultured cells and in vivo animal models [48]. Here, TARBP2 is linked to cancer.